GlaxoSmithKline and CureVac are to begin developing a next generation vaccine targeting emerging variants of the coronavirus – although it is unlikely to be ready until at least next year.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...

Once upon a time, you might have been hard-pressed to find European ready-to-wear, Michelin-starred cuisine, or blue-chip art in New Zealand—even in Auckland, its most cosmopolitan city.

Five years since the start of the COVID pandemic, it can feel as if trust in the knowledge of experts and scientific evidence ...

Governments regularly focus on doubling exports to improve the economy. While the goal may be aspirational, there are ways to ...

Teva Pharmaceutical Industries Ltd. ADR-0.95% $24.61B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

At close: January 24 at 5:31:12 PM GMT ...

After hours: 24 January at 18:49:02 GMT-5 ...